Drug Shortage Report for PROTAMINE SULFATE INJECTION USP

Last updated on 2021-05-03 History
Report ID 138125
Drug Identification Number 02231674
Brand name PROTAMINE SULFATE INJECTION USP
Common or Proper name PROTAMINE SULFATE INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PROTAMINE SULFATE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25ML 1LIVI CA
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-23
Estimated end date 2021-10-01
Actual end date
Shortage status Actual shortage
Updated date 2021-05-03
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-05-03 French Compare
v3 2021-05-03 English Compare
v2 2021-04-27 French Compare
v1 2021-04-27 English Compare